All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
RP 59500
Known as:
RP-59500
Â
Â
National Institutes of Health
Topic mentions per year
Topic mentions per year
1991-2000
0
5
10
1991
2000
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.
Marcus W. Griswold
,
Ben M Lomaestro
,
Laurie L Briceland
American journal of health-system pharmacy : AJHP…
1996
The pharmacology, pharmacokinetics, activity, and potential clinical role of quinupristin-dalfopristin (RP 59500) are described…Â
(More)
Is this relevant?
1996
1996
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Glenn A. Pankuch
,
Cornelia Lichtenberger
,
Mark Jacobs
,
Paul Appelbaum
Antimicrobial agents and chemotherapy
1996
Previous time-kill studies have shown that RP 59500 is rapidly bactericidal against pneumococci. To extend these findings, the…Â
(More)
Is this relevant?
1995
1995
In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.
C. C. Johnson
,
L A Slavoski
,
+4 authors
Moshe Levison
Diagnostic microbiology and infectious disease
1995
The activity of RP 59500 (quinupristin/dalfopristin) was evaluated in vitro against antibiotic-resistant strains of Streptococcus…Â
(More)
Is this relevant?
1992
1992
Comparative in-vitro activity of RP 59500.
Lieve Verbist
,
Jan L Verhaegen
The Journal of antimicrobial chemotherapy
1992
The in-vitro activity of RP 59500 was compared with that of other appropriate antibiotics against 131 staphylococci, 97…Â
(More)
Is this relevant?
1992
1992
In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
William Brumfitt
,
J M.T. Hamilton-miller
,
S. Shah
The Journal of antimicrobial chemotherapy
1992
A study of the in-vitro activity of RP 59500, a semisynthetic derivative of pristinamycin, against a range of Gram-positive…Â
(More)
Is this relevant?
1992
1992
Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.
Roland Leclercq
,
L Nantas
,
C. J. Soussy
,
Jérôme F. L. Duval
The Journal of antimicrobial chemotherapy
1992
RP 59500 is a semisynthetic streptogramin (Sg) composed of two synergic components: RP 57669 and RP 54476. The activities of RP…Â
(More)
Is this relevant?
1992
1992
In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
david. bouanchaud
The Journal of antimicrobial chemotherapy
1992
RP 59500 is a new semisynthetic injectable streptogramin antibiotic composed of two compounds which interact synergically, RP…Â
(More)
Is this relevant?
1992
1992
In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
J C Péchère
The Journal of antimicrobial chemotherapy
1992
The in-vitro activity of RP 59500, an injectable streptogramin derived from pristinamycin, was determined by agar dilution and…Â
(More)
Is this relevant?
1992
1992
Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Megumi Inoue
,
Roberta Okamoto
,
Tomoharu Okubo
,
K. Inoue
,
Shoichi Mitsuhashi
The Journal of antimicrobial chemotherapy
1992
The activity of RP 59500 against Gram-positive cocci was determined by an agar dilution method and compared with that of…Â
(More)
Is this relevant?
1991
1991
In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.
Raphael Fass
Antimicrobial agents and chemotherapy
1991
The in vitro activity of RP 59500, a semisynthetic pristinamycin, was compared with the activities of vancomycin, oxacillin…Â
(More)
Is this relevant?